Response phenotype as a predictive biomarker to guide treatment with targeted therapies
- PMID: 24043750
- DOI: 10.1200/JCO.2013.51.8365
Response phenotype as a predictive biomarker to guide treatment with targeted therapies
Comment on
-
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab.J Clin Oncol. 2013 Oct 20;31(30):3764-75. doi: 10.1200/JCO.2012.42.8532. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043732 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
